Gabelli Funds LLC Vertex Pharmaceuticals Inc Transaction History

Gabelli Funds LLC

$12.3 Billion
Q2 2024

A detailed history of Gabelli Funds LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Gabelli Funds LLC holds 22,092 shares of VRTX stock, worth $10.2 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

22,092

Previous 22,309 0.97%

Holding current value

$10.2 Million

Previous $9.33 Million 11.03%

% of portfolio

0.08%

Previous 0.07%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$392.81 - $485.53 $85,239 - $105,360	-217 Reduced 0.97%	22,092 $10.4 Million
Q1 2024 May 14, 2024	SELL	$407.69 - $446.08 $195,691 - $214,118	-480 Reduced 2.11%	22,309 $9.33 Million
Q4 2023 Feb 13, 2024	BUY	$343.0 - $410.68 $36,015 - $43,121	105 Added 0.46%	22,789 $9.27 Million
Q3 2023 Nov 08, 2023	SELL	$338.18 - $362.46 $157,253 - $168,543	-465 Reduced 2.01%	22,684 $7.89 Million
Q2 2023 Aug 10, 2023	SELL	$314.42 - $351.91 $469,114 - $525,049	-1,492 Reduced 6.05%	23,149 $8.15 Million
Q1 2023 May 12, 2023	BUY	$283.23 - $323.1 $418,330 - $477,218	1,477 Added 6.38%	24,641 $7.76 Million
Q4 2022 Feb 13, 2023	BUY	$285.76 - $321.48 $330,910 - $372,273	1,158 Added 5.26%	23,164 $6.69 Million
Q3 2022 Nov 10, 2022	SELL	$273.83 - $305.53 $1.12 Million - $1.25 Million	-4,095 Reduced 15.69%	22,006 $6.37 Million
Q2 2022 Aug 12, 2022	SELL	$234.96 - $292.55 $2.79 Million - $3.47 Million	-11,861 Reduced 31.24%	26,101 $7.36 Million
Q1 2022 May 13, 2022	BUY	$221.42 - $260.97 $1.48 Million - $1.74 Million	6,666 Added 21.3%	37,962 $9.91 Million
Q4 2021 Feb 11, 2022	BUY	$177.01 - $223.45 $1.06 Million - $1.34 Million	6,000 Added 23.72%	31,296 $6.87 Million
Q3 2021 Nov 12, 2021	BUY	$181.39 - $202.99 $2.8 Million - $3.13 Million	15,421 Added 156.16%	25,296 $4.59 Million
Q2 2021 Aug 13, 2021	BUY	$187.49 - $221.1 $1.85 Million - $2.18 Million	9,875 New	9,875 $1.99 Million

Others Institutions Holding VRTX

# of Institutions

1,707

Shares Held

226M

Call Options Held

1.2M

Put Options Held

1.59M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $119B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gabelli Funds LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gabelli Funds LLC with notifications on news.

Account

Gabelli Funds LLC Vertex Pharmaceuticals Inc Transaction History